BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 28820329)

  • 1. Sources to variability in circulating human miRNA signatures.
    Keller A; Rounge T; Backes C; Ludwig N; Gislefoss R; Leidinger P; Langseth H; Meese E
    RNA Biol; 2017 Dec; 14(12):1791-1798. PubMed ID: 28820329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of a healthy miRNome with melanoma patient miRNomes: are microRNAs suitable serum biomarkers for cancer?
    Margue C; Reinsbach S; Philippidou D; Beaume N; Walters C; Schneider JG; Nashan D; Behrmann I; Kreis S
    Oncotarget; 2015 May; 6(14):12110-27. PubMed ID: 25883223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Towards Clinical Applications of Blood-Borne miRNA Signatures: The Influence of the Anticoagulant EDTA on miRNA Abundance.
    Leidinger P; Backes C; Rheinheimer S; Keller A; Meese E
    PLoS One; 2015; 10(11):e0143321. PubMed ID: 26599228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating miRNome detection analysis reveals 537 miRNAS in plasma, 625 in extracellular vesicles and a discriminant plasma signature of 19 miRNAs in children with retinoblastoma from which 14 are also detected in corresponding primary tumors.
    Castro-Magdonel BE; Orjuela M; Alvarez-Suarez DE; Camacho J; Cabrera-Muñoz L; Sadowinski-Pine S; Medina-Sanson A; Lara-Molina C; García-Vega D; Vázquez Y; Durán-Figueroa N; Orozco-Romero MJ; Hernández-Ángeles A; Ponce-Castañeda MV
    PLoS One; 2020; 15(4):e0231394. PubMed ID: 32287312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA Expression in Formalin-fixed Paraffin-embedded Cancer Tissue: Identifying Reference MicroRNAs and Variability.
    Boisen MK; Dehlendorff C; Linnemann D; Schultz NA; Jensen BV; Høgdall EV; Johansen JS
    BMC Cancer; 2015 Dec; 15():1024. PubMed ID: 26714641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Towards a new standardized method for circulating miRNAs profiling in clinical studies: Interest of the exogenous normalization to improve miRNA signature accuracy.
    Vigneron N; Meryet-Figuière M; Guttin A; Issartel JP; Lambert B; Briand M; Louis MH; Vernon M; Lebailly P; Lecluse Y; Joly F; Krieger S; Lheureux S; Clarisse B; Leconte A; Gauduchon P; Poulain L; Denoyelle C
    Mol Oncol; 2016 Aug; 10(7):981-92. PubMed ID: 27083764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiRNA profiles in blood plasma from mother-child duos in human biobanks and the implication of sample quality: Circulating miRNAs as potential early markers of child health.
    Dypås LB; Gützkow KB; Olsen AK; Duale N
    PLoS One; 2020; 15(4):e0231040. PubMed ID: 32240265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intra-individual variation of miRNA expression levels in human plasma samples.
    Wu J; Cai H; Xiang YB; Matthews CE; Ye F; Zheng W; Cai Q; Shu XO
    Biomarkers; 2018; 23(4):339-346. PubMed ID: 29378466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymer-Based Precipitation of Extracellular Vesicular miRNAs from Serum Improve Gastric Cancer miRNA Biomarker Performance.
    Chung KY; Quek JM; Neo SH; Too HP
    J Mol Diagn; 2020 May; 22(5):610-618. PubMed ID: 32151712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantification of circulating miRNAs in plasma: effect of preanalytical and analytical parameters on their isolation and stability.
    Sourvinou IS; Markou A; Lianidou ES
    J Mol Diagn; 2013 Nov; 15(6):827-34. PubMed ID: 23988620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A circulating miRNA signature as a diagnostic biomarker for non-invasive early detection of breast cancer.
    Zhang L; Xu Y; Jin X; Wang Z; Wu Y; Zhao D; Chen G; Li D; Wang X; Cao H; Xie Y; Liang Z
    Breast Cancer Res Treat; 2015 Nov; 154(2):423-34. PubMed ID: 26476723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating microRNAs as emerging cardiac biomarkers responsive to acute exercise.
    de Gonzalo-Calvo D; Dávalos A; Fernández-Sanjurjo M; Amado-Rodríguez L; Díaz-Coto S; Tomás-Zapico C; Montero A; García-González Á; Llorente-Cortés V; Heras ME; Boraita Pérez A; Díaz-Martínez ÁE; Úbeda N; Iglesias-Gutiérrez E
    Int J Cardiol; 2018 Aug; 264():130-136. PubMed ID: 29776561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small RNAs have a large impact: circulating microRNAs as biomarkers for human diseases.
    Weiland M; Gao XH; Zhou L; Mi QS
    RNA Biol; 2012 Jun; 9(6):850-9. PubMed ID: 22699556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific miRNA Disease Biomarkers in Blood, Serum and Plasma: Challenges and Prospects.
    Backes C; Meese E; Keller A
    Mol Diagn Ther; 2016 Dec; 20(6):509-518. PubMed ID: 27378479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A unique set of 6 circulating microRNAs for early detection of non-small cell lung cancer.
    Halvorsen AR; Bjaanæs M; LeBlanc M; Holm AM; Bolstad N; Rubio L; Peñalver JC; Cervera J; Mojarrieta JC; López-Guerrero JA; Brustugun OT; Helland Å
    Oncotarget; 2016 Jun; 7(24):37250-37259. PubMed ID: 27191990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a plasma miRNA biomarker signature for allergic asthma: A translational approach.
    Milger K; Götschke J; Krause L; Nathan P; Alessandrini F; Tufman A; Fischer R; Bartel S; Theis FJ; Behr J; Dehmel S; Mueller NS; Kneidinger N; Krauss-Etschmann S
    Allergy; 2017 Dec; 72(12):1962-1971. PubMed ID: 28513859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum microRNA signatures as "liquid biopsies" for interrogating hepatotoxic mechanisms and liver pathogenesis in human.
    Krauskopf J; de Kok TM; Schomaker SJ; Gosink M; Burt DA; Chandler P; Warner RL; Johnson KJ; Caiment F; Kleinjans JC; Aubrecht J
    PLoS One; 2017; 12(5):e0177928. PubMed ID: 28545106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distribution of microRNA biomarker candidates in solid tissues and body fluids.
    Fehlmann T; Ludwig N; Backes C; Meese E; Keller A
    RNA Biol; 2016 Nov; 13(11):1084-1088. PubMed ID: 27687236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of microRNA biomarkers in the blood of breast cancer patients based on microRNA profiling.
    Zhang K; Wang YW; Wang YY; Song Y; Zhu J; Si PC; Ma R
    Gene; 2017 Jul; 619():10-20. PubMed ID: 28359916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Profiles of differential expression of circulating microRNAs in hepatitis B virus-positive small hepatocellular carcinoma.
    Wang Y; Gao Y; Shi W; Zhai D; Rao Q; Jia X; Liu J; Jiao X; Du Z
    Cancer Biomark; 2015; 15(2):171-80. PubMed ID: 25519019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.